The analysis indicated that the HAT1 gene was negatively correlated with PAH risk, suggesting a potential protective role, whereas the S100A10 and TAGLN2 genes were positively correlated with PAH risk, implying that these genes may promote disease development. This evidence concerns the gene TAGLN2 and pulmonary arterial hypertension.